Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Sol-Gel Technologies Ltd (SLGL)

Sol-Gel Technologies Ltd (SLGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Sol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Lags Revenue Estimates Zacks - Fri Mar 10, 2023

Sol-Gel Technologies Ltd. (SLGL) delivered earnings and revenue surprises of -92.31% and 94.60%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the...

SLGL : 0.8896 (+3.32%)
SENS : 0.4157 (-0.60%)
Homology Medicines (FIXX) Reports Q4 Loss, Misses Revenue Estimates Zacks - Thu Mar 9, 2023

Homology Medicines (FIXX) delivered earnings and revenue surprises of -17.65% and 23.62%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

FIXX : 16.8246 (+0.77%)
SLGL : 0.8896 (+3.32%)
Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Beat Estimates Zacks - Tue Feb 28, 2023

Amphastar (AMPH) delivered earnings and revenue surprises of 92.11% and 6.80%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

AMPH : 41.11 (+0.69%)
SLGL : 0.8896 (+3.32%)
Zacks Industry Outlook Highlights Dr. Reddy's, Amphastar Pharmaceuticals and Sol-Gel Technologies Zacks - Thu Dec 8, 2022

Dr. Reddy's, Amphastar Pharmaceuticals and Sol-Gel Technologies have been highlighted in this Industry Outlook article.

RDY : 74.55 (+0.72%)
AMPH : 41.11 (+0.69%)
SLGL : 0.8896 (+3.32%)
3 Generic Drug Stocks to Watch Amid Inflation Pressures Zacks - Wed Dec 7, 2022

The impact of inflationary headwinds and pricing pressure on the Zacks Medical - Generic Drugs industry persists. New product launches provide some respite to AMPH, RDY and SLGL.

RDY : 74.55 (+0.72%)
AMPH : 41.11 (+0.69%)
SLGL : 0.8896 (+3.32%)
SolGel Technologies Ltd. (SLGL) Reports Q3 Loss, Misses Revenue Estimates Zacks - Thu Nov 10, 2022

SolGel Technologies Ltd. (SLGL) delivered earnings and revenue surprises of -114.29% and 92.44%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

SLGL : 0.8896 (+3.32%)
FIXX : 16.8246 (+0.77%)
Bausch Health (BHC) Misses Q3 Earnings and Revenue Estimates Zacks - Thu Nov 3, 2022

Bausch (BHC) delivered earnings and revenue surprises of -17.39% and 2.21%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

BHC : 8.71 (+1.04%)
SLGL : 0.8896 (+3.32%)
Zacks Industry Outlook Highlights Teva, Dr. Reddy's and Sol-Gel Zacks - Mon Sep 12, 2022

Teva, Dr. Reddy's and Sol-Gel have been highlighted in this Industry Outlook article.

RDY : 74.55 (+0.72%)
TEVA : 13.81 (+4.23%)
SLGL : 0.8896 (+3.32%)
3 Generic Drug Stocks to Watch Amid Continued Pricing Pressure Zacks - Fri Sep 9, 2022

The impact of COVID-19 and pricing pressure on the Zacks Medical - Generic Drugs industry persists. New product launches provide some respite to TEVA, RDY and SLGL.

TEVA : 13.81 (+4.23%)
RDY : 74.55 (+0.72%)
SLGL : 0.8896 (+3.32%)
SolGel Technologies Ltd. (SLGL) Reports Q2 Loss, Misses Revenue Estimates Zacks - Thu Aug 4, 2022

SolGel Technologies Ltd. (SLGL) delivered earnings and revenue surprises of 90% and 27.46%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

SLGL : 0.8896 (+3.32%)
FIXX : 16.8246 (+0.77%)

Barchart Exclusives

3 Highest-Yielding (And Safest) Dividend Aristocrats To Buy Today Barchart - 39 minutes ago
The highest-yielding dividend aristocrats aren't always the safest stocks to buy. Here's what I did to counteract this. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot